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Background: The nucleotide second messengers cAMP and c-di-GMP allow many bacteria, including the
human intestinal pathogen Vibrio cholerae, to respond to environmental stimuli with appropriate physiological
adaptations. In response to limitation of specific carbohydrates, cAMP and its receptor CRP control the transcription of
genes important for nutrient acquisition and utilization; c-di-GMP controls the transition between motile and sessile
lifestyles often, but not exclusively, through transcriptional mechanisms. In this study, we investigated the convergence
of cAMP and c-di-GMP signaling pathways in regulating the expression of gbpA. GbpA is a colonization factor
that participates in the attachment of V. cholerae to N-acetylglucosamine-containing surfaces in its native
aquatic environment and the host intestinal tract.
Results: We show that c-di-GMP inhibits gbpA activation in a fashion independent of the known transcription
factors that directly sense c-di-GMP. Interestingly, inhibition of gbpA activation by c-di-GMP only occurs during
growth on non-PTS dependent nutrient sources. Consistent with this result, we show that CRP binds to the
gbpA promoter in a cAMP-dependent manner in vitro and drives transcription of gbpA in vivo. The interplay
between cAMP and c-di-GMP does not broadly impact the CRP-cAMP regulon, but occurs more specifically at
the gbpA promoter.
Conclusions: These findings suggest that c-di-GMP directly interferes with the interaction of CRP-cAMP and the gbpA
promoter via an unidentified regulator. The use of two distinct second messenger signaling mechanisms to regulate
gbpA transcription may allow V. cholerae to finely modulate GbpA production, and therefore colonization of aquatic
and host surfaces, in response to discrete environmental stimuli.Background
Nucleotide second messengers in bacteria play a key
role in relaying information from the extracellular en-
vironment to intracellular effectors, resulting in an
adaptive physiological response. Production of these
intracellular nucleotides, which include c-di-GMP, c-
di-AMP, cGMP, cAMP, and (p)ppGpp, regulates funda-
mental processes relating including biofilm formation,
motility, nutrient acquisition, stress responses, sporu-
lation and, in some pathogens, virulence factor pro-
duction (reviewed in [1–4]).* Correspondence: rita_tamayo@med.unc.edu
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article, unless otherwise stated.C-di-GMP, utilized by many Gram-negative and Gram-
positive bacteria, usually regulates transitions between
motile and non-motile lifestyles. Specifically, c-di-GMP
negatively regulates flagellar motility by inhibiting flagel-
lum biosynthesis or function, and positively regulates ad-
herence and biofilm development in many species [5].
The intracellular levels of c-di-GMP are regulated by the
opposing activities of diguanylate cyclase (DGC) biosyn-
thetic enzymes and phosphodiesterase (PDE) hydrolytic
enzymes [6–12]. Many organisms contain numerous
genes that encode proteins with known or predicted func-
tions as DGC and/or PDE enzymes. To date there are sev-
eral known intracellular c-di-GMP receptors, including
protein and RNA-based sensors. Proteins that directly
sense c-di-GMP include transcription factors, proteins
containing the well-characterized PilZ domain, and otherse is distributed under the terms of the Creative Commons Attribution 4.0
ns.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
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indicate if changes were made. The Creative Commons Public Domain
.org/publicdomain/zero/1.0/) applies to the data made available in this
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to bind c-di-GMP [13]. In addition, two distinct classes of
c-di-GMP sensing riboswitch, broadly present in bacterial
genomes, have been identified [14–17]. The presence of
numerous c-di-GMP metabolic enzymes and an array of
intracellular c-di-GMP receptors points to complex c-di-
GMP signaling networks that modulates a wide array of
cellular functions.
In the human diarrheal pathogen Vibrio cholerae, c-di-
GMP promotes biofilm formation and inhibits flagellar mo-
tility [18–20]; in addition, c-di-GMP inhibits the expression
of virulence genes including those encoding the major viru-
lence factor, cholera toxin [21]. To date, three transcription
factors that directly sense c-di-GMP have been identified in
V. cholerae: VpsT, VpsR and FlrA [22–24]. Each of these
was previously characterized as a regulator of biofilm for-
mation and/or motility [20, 25–28]. Five proteins contain-
ing a PilZ domain have been described in V. cholerae, some
of which have roles in biofilm, motility and/or virulence
[29]. The V. cholerae genome also encodes two c-di-GMP
riboswitches, Vc1 and Vc2, which lie upstream of gbpA and
VC1722, respectively [14].
cAMP signaling is widespread in bacteria, and intracel-
lular cAMP levels are heavily influenced by the avail-
ability of extracellular nutrient sources [30]. In
Gram-negative bacteria, uptake of a preferred sugar
by the phosphoenolpyruvate-carbohydrate phospho-
transferase transport system (PTS) relies on a sugar-
specific transporter, EIIA. Following uptake of a PTS
sugar, EIIA and other PTS components participate in
a phosphorylation cascade that culminates phospho-
transfer from EIIA to the incoming sugar. The phos-
phorylation state of EIIA serves as a measure of PTS
sugar availability. Under conditions of PTS sugar
limitation (and absence of a PTS sugar substrate),
EIIA remains phosphorylated and stimulates the ad-
enylate cyclase (AC), triggering cAMP biosynthesis.
To date, the only known sensor of cAMP in bacteria
is the cAMP receptor protein (CRP) [30]. Together,
the cAMP-CRP complex promotes the expression of
genes involved in the uptake and utilization of non-
PTS nutrient sources.
V. cholerae uses the cAMP-CRP system to respond to
the absence of PTS-dependent sugars such as N-acetylglu-
cosamine, sucrose, mannitol and fructose [31]. Unlike
E. coli, in which glucose utilization is PTS-dependent,
glucose can be utilized via PTS and non-PTS mecha-
nisms in V. cholerae [31]. V. cholerae has also adapted
the cAMP-CRP pathway to promote motility and in-
hibit biofilm formation [32, 33]. Transcriptome analyses
have shown that cya and crp deletion mutants (which
lack cAMP biosynthesis and sensing, respectively) have
increased expression of genes involved in extracellular
matrix production, reduced expression of genes involvedin flagellum biosynthesis and chemotaxis [32, 33]. In
addition, a crp deletion mutant has reduced expres-
sion of genes important for colonization and is atten-
uated in a mouse model of infection [32]. Interestingly,
the cAMP-CRP signaling pathway impinges upon the
c-di-GMP signaling network; a crp mutant has altered
expression of numerous genes involved in c-di-GMP
metabolism [33].
V. cholerae naturally inhabits aquatic reservoirs, where
it associates with chitinous surfaces such the exoskele-
tons of zooplankton and crustaceans [34]. V. cholerae
can be ingested through consumption of contaminated
food or water and subsequently colonize the small in-
testine and cause diarrheal disease in humans. The
colonization factor GbpA aids in the attachment of V.
cholerae to surfaces in its native aquatic environment
and in the host intestine [35, 36]. GbpA recognizes N-
acetylglucosamine (GlcNAc), a component of mucin
and a modification of glycoprotein and lipids found on
the surface of the intestinal epithelium, thus mediating
interactions with the host intestinal epithelium [35, 36].
GlcNAc also comprises the polymer chitin, a major
component of the exoskeletons of crustaceans and zoo-
plankton, thus serving as a substratum for V. cholerae
colonization in aquatic reservoirs [35]. In addition to
serving as a ligand for GbpA, GlcNAc also regulates
gbpA expression via the transcriptional regulator NagC
[37, 38]. In V. cholerae and some other bacterial spe-
cies, the transcription factor NagC regulates gene expres-
sion in response to GlcNAc and typically controls genes
involved in GlcNAc uptake and metabolism [38–42].
Transcriptional profiling of a V. cholerae nagC mutant in-
dicated that NagC represses gbpA transcription [38], sug-
gesting that gbpA expression is down-regulated in the
presence of mucin- and chitin-derived GlcNAc in the
small intestine and in the aquatic environment, respect-
ively [36–38].
In this study, we investigated the combined roles of
the second messengers cAMP and c-di-GMP in regu-
lating gbpA transcription. We report that c-di-GMP
inhibits gbpA transcription independently of the pre-
viously described c-di-GMP riboswitch. Expression of
gbpA is also influenced by the availability of PTS-
dependent carbohydrates, and is accordingly regulated
by cAMP-CRP through direct binding of this complex
to the gbpA promoter. Together, our results indicate
that gbpA transcription is regulated by both c-di-
GMP and cAMP, in opposing fashion. The c-di-GMP
and cAMP second messenger signaling pathways may
thus function together to modulate the production of
GbpA in response to discrete extracellular stimuli,
likely impacting the ability of V. cholerae to colonize
GlcNAc-containing surfaces in the aquatic and host
environments.
Kariisa et al. BMC Microbiology  (2015) 15:166 Page 3 of 15Methods
Growth conditions and media
Escherichia coli, V. cholerae C6706 and mutant deriva-
tives were cultured at 37 °C with aeration in Luria-
Bertani (LB) broth containing 100 μg/ml streptomycin
(Sm), 10 μg/ml chloramphenicol (Cm), and/or 50 μg/ml
ampicillin (Amp), as appropriate. Where specified, V.
cholerae was grown in M9 minimal medium (Fisher
Scientific) supplemented with trace metals (1 ml l−1 of
5 % MgSO4, 0.5 % MnCl24H2O, 0.5 % FeCl3, 0.4 %
nitrilotriacetic acid) [43] and 0.5 % (w/v) of the indi-
cated carbon source.
Strain construction
Strains and plasmids included in this study are listed in
Additional file 1: Table S1. Primer information is con-
tained in Additional file 1: Table S2. The gbpA, nagC,
crp, cpdA, cya, vpsT, vpsR and flrA genes were mutated
by standard allelic exchange methods. A deletion in the
Vc1 sequence upstream of gbpA was deleted in a similar
manner. Using genomic DNA from V. cholerae C6706 as
template, ~800 bp fragments upstream and downstream
of the sequences to be deleted were amplified by PCR
using primers named according to the pattern geneF1 +
geneR1 for the upstream region of homology and
geneF2 + geneR2 for the downstream region of hom-
ology. The primers introduced restriction sites (under-
lined sequences in Table S2) allowing ligation of the
resulting fragments to each other and into the pCVD442
suicide vector. The exception is the vpsR mutation, for
which the two fragments were joined by splicing by
overlap extension, and then ligated into pCVD442. The
ligations were transformed into DH5αλpir by electropor-
ation and transformed colonies were identified on LB-
Amp agar. The desired clones containing the up-
stream and downstream fragments were identified by
PCR using primers geneF1 + geneR2 and/or pCVDseqF +
pCVDseqR, which flank the multiple cloning site of
pCVD442. The allelic exchange steps were done as de-
scribed previously [44]. Colonies were screened for the de-
sired deletion by PCR using the corresponding geneF0 +
geneR2 primers.
VC1592, which encodes an EAL domain c-di-GMP
phosphodiesterase [45, 46], was amplified from C6706
genomic DNA using primers VC1592eF + VC1592eH6R.
The product was digested with SacI and PstI, ligated into
similarly digested pBAD33, and transformed into DH5α.
Cm-resistant transformants were screened for the desired
insert by PCR, and isolates were confirmed by sequencing.
The pPgbpA-Vc1-lacZ and pPgbpA-ΔVc1-lacZ plas-
mids were constructed by amplifying the gbpA promoter
and 5′ UTR from V. cholerae C6706 and ΔVc1 genomic
DNA, respectively, by PCR using gbpAP2F + gbpAR2.
The PCR products were digested with EcoRI and SalIand ligated into pPlacthiM#2-lacZ [47] digested with
the same enzymes. The ligation reaction was trans-
formed into DH5α cells by electroporation, and Amp-
resistant colonies obtained were screened with primers
pLacSeq + gbpAR2. The resulting plasmids have PgbpA-
UTR (wild type or ΔVc1) as a translational fusion to
lacZ, with the lac promoter driving transcription. The
plasmids were introduced by electroporation into V.
cholerae C6706 in which the endogenous lacZ gene was
inactivated [48].
The pBAD33, pPDE (pBAD33::vieA), pPDEmut (pBAD33::
vieA-E170A), and pVC1592 (pBAD33::VC1592) plasmids
were introduced into the indicated strains by electropor-
ation. Cm-resistant isolates were confirmed to have the de-
sired plasmid by PCR.
Manipulation of the intracellular c-di-GMP level in
V. cholerae
The intracellular c-di-GMP level was depleted through
the ectopic expression of a V. cholerae c-di-GMP
phosphodiesterase gene, vieA, as described previously
[49, 50]. Briefly, V. cholerae bearing pBAD33 (“vector”)
or pBAD33::vieA (“pPDE”) were grown in 2 ml LB-Sm-
Cm broth at 37 °C with aeration. Ampicillin was in-
cluded at 50 μg/ml if the strains also contained a lacZ
reporter plasmid. For the indicated experiments,V. cho-
lerae with pPDEmut (encoding enzymatically inactive
VieA PDE) or pVC1592 (encoding an alternative c-di-
GMP PDE) were included [45]. At early exponential
phase (OD600 ~ 0.2), 0.2 % L-arabinose was added to
the cultures to induce vieA transcription from the PBAD
promoter, and incubations were continued at 37 °C
with aeration. Samples were collected at mid-
exponential phase (optical density at 600 nm (OD600) ~
0.5-0.7) for western blotting or qRT-PCR analysis as de-
scribed below.
Reporter activity assays
The β-galactosidase activity was measured for V. cho-
lerae strains containing the PgbpA-Vc1-lacZ fusion, with
vector (pBAD33) or pPDE. Strains were grown in
2 ml M9 minimal medium with 0.5 % (w/v) glucose,
maltose, sucrose, fructose or casamino acids. Ampicillin
(50 μg/ml) and/or chloramphenicol (10 μg/ml) were
included in the media as appropriate to maintain
plasmids. Cultures were incubated at 37 °C with aer-
ation. Expression of the vieA PDE gene was induced
using 0.2 % L-arabinose as described above. Samples
were grown to mid-exponential phase (OD600 0.45-0.6),
and 100 μl were assayed for hydrolysis of ortho-
nitrophenyl-β-D-galactoside using a Miller assay [51]. At
least three independent experiments were done, and the
data were combined. Statistical analyses were done using
unpaired t-tests.
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Anti-GbpA antiserum was produced by Yenzym 192
Antibodies, LLC, South San Francisco, CA. Antiserum
was raised in rabbits to a synthetic peptide (CSNAT-
QYQPGTGSHWEMAWDKR) that corresponds to GbpA
from V. cholerae. The animal facilities were NIH/OLAW/
PHS assured, USDA certified, and IACUC regulated.
GbpA and CRP detection by western blot
Equal-volume samples of mid-exponential phase cul-
tures, normalized to OD600 (0.45-0.6), were collected.
For detection of GbpA, the samples were centrifuged
to remove the bacteria. Supernatant proteins were
TCA precipitated, separated by electrophoresis, and
subjected to western blotting with rabbit anti-GbpA
antibodies. For detection of CRP, cells grown as above
were collected by centrifugation. Whole lysates were
electrophoresed and transferred to nitrocellulose mem-
branes. CRP (~23.6 kDa) was detected using anti-CRP
monoclonal antibodies (Neoclone). For cell lysates, RNA
Polymerase β subunit (~150 kDa) served as a loading con-
trol and was detected with monoclonal antibodies
(AbCam). In all western blots, goat α-rabbit IgG conju-
gated with IR800 dye (Thermo Scientific) was used as the
secondary antibody. The blots were imaged using an
Odyssey imaging system (LI-COR). At least three inde-
pendent experiments were done, and a representative
image is shown. Densitometry analyses were done using
the Odyssey software. The intensities of the bands cor-
responding to GbpA in supernatants were normalized
to those of a cross reactive band (indicated by asterisks
in relevant images). For CRP quantification, the inten-
sities of the bands of CRP in lysates were normalized to
those of RNAP.
RNA purification and analysis using quantitative real-time
PCR
Transcriptional analyses using quantitative reverse-
transcriptase PCR (qRT-PCR) were done as previously
described [52]. Briefly, RNA was purified from mid-
exponential phase (OD600 ~ 0.5-0.7) cultures. Genomic
DNA was removed using the TURBO DNA-free kit
(Ambion). For cDNA synthesis, RNA (200 ng) was re-
verse transcribed using the Tetro cDNA Synthesis Kit
(Bioline). We included control reactions without reverse
transcriptase for every cDNA sample. For the real time
PCR reaction, cDNA and control samples were com-
bined with 2× SYBR/fluorescein mix (SensiMix; Bioline)
and 7.5 μM of each primer (named according to the
scheme gene-qF and gene-qR for forward and reverse
primers, respectively, Additional file 1: Table S2). We
used the following program to amplify target cDNA: 95 °C
for 10 min, followed by 40 cycles of 95 °C for 30 s, 55 °C
for 1 min, and 72 °C for 30 s. Melt curves wereincluded to verify amplification of single products.
The data were analyzed using the ΔΔCt method, with
Ct values normalized to the specified reference strain/
condition, and to the Ct values of the reference gene
rpoB and/or gyrA in each sample [52–54]. For each
strain/condition, a minimum of three independent
samples was tested. Statistical significance was deter-
mined by unpaired t-test.
Cloning and expression of crp and purification of the
recombinant protein
The CRP gene was amplified from V. cholerae C6706
genomic DNA using primers CRPeF + CRPeH6R,
which incorporate EcoRI and SalI restriction sites into
the product, respectively. The CRPeH6R primer intro-
duces 6 histidine codons at the 3′ end of the gene.
The PCR product was digested with EcoRI and SalI
and ligated into similarly digested pMMB67EH, a
low-copy vector allowing IPTG-inducible gene expres-
sion [55]. Ligations were transformed into E. coli
DH5α cells. Ampicillin-resistant colonies containing
pMMB67EH with crp-his6 insert were identified by
PCR, yielding pMMB::crp-his6.
E. coli DH5α containing pMMB::crp-his6 was grown
in LB broth at 37 °C with aeration to early exponential
phase (OD600 ~ 0.2), at which point IPTG was added for
a 0.5 mM final concentration. The culture was grown at
37 °C with aeration to mid- exponential phase (OD
600 nm ~ 0.7), then cells were collected by centrifuga-
tion. Cells were suspended in His6 lysis buffer consisting
of 10 mm Tris, pH 8, 300 mm NaCl, 50 mm NaH2PO4,
10 % glycerol, 1 mm phenylmethylsulfonyl fluoride, and
5 mM imidazole [10]. The cells were lysed by sonication,
and CRP was purified by affinity chromatography with
Ni-NTA resin (ThermoFisher) using the general
methods described previously [10, 50]. The eluates
were analyzed by SDS-PAGE and coomassie staining.
CRP-containing fractions were dialyzed against 5 mM
Tris 8.0, 10 mM MgCl2, 5 mM KCl, 5 mM CaCl2,
10 % glycerol using 10,000 MWCO Slide-A-Lyzer
Dialysis Cassettes (Thermo Scientific). The CRP prep-
arations were estimated to be > 95 % pure. Glycerol
was added to a final concentration of 20 %, and the
protein concentration was determined using the BCA
Protein Assay Kit (Pierce). Aliquots of the protein
were stored at −20 °C.
Electrophoretic mobility shift assays (EMSAs)
A 293 base pair gbpA promoter fragment was amplified
from V. cholerae C6706 genomic DNA using primers
gbpAP2F + Vc1R2. A 133 base pair non-specific control
DNA fragment internal to the gbpA ORF was amplified
with gbpAqF2 + gbpAqR2. EMSAs were done as previ-
ously described [56]. Binding reactions were done in
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0.1 mM DTT, 5 % glycerol (v/v) and 0.01 mg/ml BSA
(final concentrations). The gbpA promoter fragment,
CRP, and cAMP (Sigma-Aldrich) were used at final
concentrations of 2.5 ng/μl, 11 ng/μl, and 33 μM, re-
spectively. C-di-GMP (Biolog) was used at 33 μM, or
333 μM when in competition with cAMP. The non-
specific DNA fragment (75 ng) was added to every
mixture. After 1 h incubation at room temperature
(~25 °C), the samples were electrophoresed on a 6 %
TAE polyacrylamide gel. The gel was stained with
GelRed (Biotium, Inc.) in TAE for 10 min, and then
visualized under UV light.
Results
Low c-di-GMP induces gbpA transcription
A putative c-di-GMP riboswitch, named Vc1, was previ-
ously predicted upstream of the gbpA open reading
frame [14]. The Vc1 element shares 75 % identity with
the well-characterized c-di-GMP riboswitch Vc2, which
has been shown to bind c-di-GMP directly and positively
regulate expression of a reporter gene in response to c-
di-GMP in a heterologous bacterial host [14]. The iden-
tification of the putative c-di-GMP riboswitch Vc1 up-
stream of gbpA suggests that gbpA expression is
regulated by this signaling molecule. To test this, we
used a previously described strategy for manipulating
intracellular c-di-GMP levels in V. cholerae: the ectopic
expression of a c-di-GMP metabolism gene. The expres-
sion of the vieA gene, which encodes a c-di-GMP
phosphodiesterase, has been used to artificially manipu-
late intracellular c-di-GMP in V. cholerae, resulting in
phenotypes consistent with reduced c-di-GMP: in-
creased motility, reduced biofilm formation, and in-
creased cholera toxin production [21, 50, 57]. To
establish that vieA expression similarly results in altered
intracellular c-di-GMP in V. cholerae C6706, the wild
type strain used in this study, we evaluated the effect of
vieA expression from plasmid “pPDE” on motility and
biofilm formation, which are inhibited and promoted by
c-di-GMP in V. cholerae, respectively. To assay swim-
ming motility, colonies of V. cholerae C6706 with vector
(pBAD33) or pPDE were inoculated into soft agar
medium containing 0.2 % L-arabinose to induce gene ex-
pression, and expansion from the inoculation point was
monitored. V. cholerae C6706 with pPDE showed signifi-
cantly increased motility compared to the vector control
(Additional file 2: Figure S1A). Importantly, V. cholerae
C6706 with pPDEmut, which contains an E170A muta-
tion that renders VieA enzymatically inactive [10],
showed motility equal to the vector control. These re-
sults indicate that c-di-GMP hydrolysis by VieA aug-
ments V. cholerae motility, consistent with previous
observations [57]. In addition, expression of anotherEAL-domain c-di-GMP PDE gene, VC1592, enhanced
motility comparably to vieA, indicating that the effect on
motility is not specific to the VieA PDE [45, 46]. To
assay biofilm formation, V. cholerae C6706 with vector
or pPDE were grown statically for 24 h in LB broth con-
taining 0.2 % L-arabinose for gene induction, and then
the biofilm biomass was evaluated by crystal violet stain-
ing. Biofilm formation of V. cholerae C6706 with pPDE
was reduced to 25 % of that generated by the vector
control strain; expression of VC1592 similarly reduced
biofilm production (Additional file 2: Figure S1B). Biofilm
formation of V. cholerae C6706 with pPDEmut was inter-
mediate between V. cholerae C6706 strains expressing
functional PDE genes and the vector control strain.
Combined with the motility assay results, these find-
ings indicate that ectopic production of VieA effect-
ively reduces intracellular c-di-GMP in V. cholerae
C6706, reflected by increased swimming motility and
reduced biofilm formation.
Using this expression strategy to manipulate intracellu-
lar c-di-GMP, we evaluated the effect of altering c-di-
GMP on the abundance of the gbpA transcript and GbpA
protein in V. cholerae with pPDE compared to V. cholerae
with vector (grown in the presence of 0.2 % L-arabinose
to drive vieA transcription as described in the Methods).
Western blot analysis of GbpA production showed that
GbpA was 2.8-fold more abundant in V. cholerae with re-
duced c-di-GMP (pPDE) (Fig. 1a). Regulation by c-di-
GMP occurred at the level of transcription, as quantitative
real time PCR analysis indicated that gbpA transcript
levels were 11.1-fold higher in V. cholerae with pPDE
(Fig. 1b). Importantly, gbpA transcript was similarly in-
creased in V. cholerae with pVC1592, in which the alter-
native c-di-GMP PDE is produced, and is not altered in V.
cholerae with pPDEmut, in which the enzymatically in-
active VieA is produced (Fig. 1c). These results indi-
cate the effect of VieA production on gbpA levels was
due to depletion of c-di-GMP, and not a consequence
of another regulatory function of VieA. Throughout
the remainder of the study, we used V. cholerae
C6706 with pPDE grown in the presence of arabinose
to represent low c-di-GMP conditions, with V. cho-
lerae C6706 with vector grown in the same condi-
tions serving as the wild-type c-di-GMP control.
c-di-GMP inhibition of gbpA transcription is independent
of the putative riboswitch Vc1
We next tested whether c-di-GMP induction of GbpA
production is dependent on the putative riboswitch
Vc1. To do this, we assessed the effect of depleting c-di-
GMP in V. cholerae lacking the Vc1 sequence. This strain,
ΔVc1, lacks nucleotides 17–202 of the transcript, which
encompass most of the 5′UTR including the c-di-GMP
riboswitch, but retains the native gbpA promoter and the
Fig. 1 c-di-GMP inhibits gbpA expression independently of the Vc1 riboswitch. a GbpA production by V. cholerae wild type and ΔVc1 strains, each
with vector (pBAD33) or pPDE, was determined by western blot. PDE gene expression was induced as described in the Methods. The image shown is
a representative of three independent experiments. Densitometry analyses were done by normalizing the intensities of the bands corresponding to
GbpA to the intensities of a cross-reactive band in the same lane (indicated by an asterisk), then comparing the normalized value to that of wild type
V. cholerae with vector only. The fold change relative to wild type is indicated below each lane. b qRT-PCR was used to measure gbpA transcript levels
in the strains described in (A), in V. cholerae with vector (black bars) or with pPDE (grey bars). The data were normalized relative to the
wild-type containing vector only, using rpoB as the reference gene. c PgbpA-Vc1-lacZ or PgbpA-ΔVc1-lacZ fusions were each introduced into V.
cholerae with vector (black bars) or pPDE (grey bars), and the β-galactosidase activity in culture lysates of these strains was measured. d qRT-PCR was
used to measure gbpA transcript levels in V. cholerae with vector, pPDE, pPDEmut or pVC1592. The data were normalized relative to the
wild-type containing vector, using rpoB as the reference gene. b-d Shown are the mean values and standard deviations of at least three
independent experiments. ***P < 0.001 by unpaired t-test comparing the indicated sets of data
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mids were introduced into the ΔVc1 mutant, and the
strains were assessed for changes in gbpA expression. In
the ΔVc1 strain with vector, gbpA transcript (Fig. 1b) and
GbpA protein (Fig. 1a) were diminished by 75 and 83 %,
respectively, compared to the wild type with vector, sug-
gesting that removal of nucleotides 17–202 reduces ex-
pression. Yet depletion of c-di-GMP in the ΔVc1 strain
(pPDE) increased GbpA production 3.4-fold (Fig. 1b) and
gbpA transcription 15.4-fold (Fig. 1a), an effect equivalent
to that seen in the wild type background.
In addition, we used lacZ fusions to either the wild type
gbpA promoter and 5′UTR (PgbpA-Vc1-lacZ) or the pro-
moter and 5′UTR lacking Vc1 (PgbpA-ΔVc1-lacZ) as re-
porters of gbpA expression. We measured β-galactosidase
activity in V. cholerae with these plasmid-borne reporters,
each with either vector or pPDE. In both the PgbpA-
Vc1-lacZ and PgbpA-ΔVc1-lacZ reporter strains, reduc-
tion of c-di-GMP (pPDE) resulted in a statistically
significant ~2-fold increase in β-galactosidase activity
(Fig. 1d). Thus, c-di-GMP inhibition of gbpA expres-
sion is independent of Vc1, indicating that low intracellular
c-di-GMP concentrations promote gbpA transcription initi-
ation via the gbpA promoter.
The c-di-GMP responsive regulators VpsT, VpsR and FlrA
are not involved in the regulation of gbpA transcription
by c-di-GMP
We next aimed to determine the mechanism by which
c-di-GMP inhibits gbpA transcription. We hypothesizedthat a c-di-GMP sensing transcription factor interacts
with the gbpA promoter, either inhibiting expression in
response to c-di-GMP, or alleviating activation in re-
sponse to c-di-GMP. We first focused on three previ-
ously identified c-di-GMP binding transcription factors,
VpsT, FlrA and VpsR, as potential mediators of c-di-
GMP regulation of gbpA expression [22–24]. Transcrip-
tional profiling studies analyzing V. cholerae vpsT, vpsR
and flrA mutants have implicated each of the regulators
in controlling gbpA expression [20, 58]. The FlrA protein
was recently shown to directly sense c-di-GMP, and c-
di-GMP binding inhibits the interaction of FlrA with a
target flagellar gene promoter (flrBC) [24]. Similarly,
VpsT, a well-known activator of biofilm exopolysacchar-
ide genes in V. cholerae [28], was recently shown to bind
c-di-GMP, resulting in enhanced binding to the EPS
gene promoters [22]. Finally, VpsR, another positive
regulator of V. cholerae exopolysaccharide gene expres-
sion and biofilm production [26], appears to interact dir-
ectly with c-di-GMP; unlike VpsT and FlrA, c-di-GMP
binding did not influence VpsR binding to target pro-
moters (vpsT and aphA) [23].
We tested the effect of vpsT, vpsR or flrA mutation on
gbpA expression in response to c-di-GMP. The pPDE and
control plasmids were introduced into the ΔvpsT, ΔvpsT
and ΔflrA mutants, and gbpA expression was assessed by
qRT-PCR and by western blot. Transcript analysis showed
that the flrA mutant had somewhat (1.4-fold) higher gbpA
transcript levels, and the vpsT and vpsR mutants had lower
levels (55 and 46 % decreased, respectively), than the
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tically significant, but the trends were supported by the re-
sults of the western blots comparing GbpA protein
abundance in the mutants compared to the wild type with
vector (Fig. 2a). Furthermore, depletion of c-di-GMP
(pPDE) in the ΔflrA, ΔvpsT and ΔvpsR mutants resulted in
4.8-, 9.6- and 11.0-fold increased gbpA transcript, re-
spectively, compared to the mutants with unmodified
c-di-GMP (Fig. 2b). Inhibition of gbpA expression by
c-di-GMP in the mutants and the wild type was ap-
parent at the protein level as well (Fig. 2a). The ob-
served changes were equivalent to the increase seen
in the wild type background. Thus, none of the
known c-di-GMP sensing transcription factors are re-
quired for positive regulation of gbpA expression by
depletion this second messenger. It remains possible
that c-di-GMP influences gbpA expression via theseFig. 2 Known c-di-GMP effectors FlrA, VpsT and VpsR do not regulate
gbpA in response to c-di-GMP. a GbpA levels in the supernatants of
wild type V. cholerae, ΔflrA, ΔvpsT and ΔvpsR strains, each with
wild type (vector) or reduced levels of c-di-GMP (pPDE), were
measured by western blot. PDE gene expression was induced as
described in the Methods. The image shown is a representative
of three separate experiments. Densitometry analyses were
done by comparing the intensities of the GbpA bands to the
intensities of a cross-reactive band in the same lane (indicated
by an asterisk), then normalizing the value to that of wild type
V. cholerae with vector. The fold change relative to the wild type
is indicated below each lane. b qRT-PCR was used to measure
the gbpA transcript abundance in wild type, ΔflrA, ΔvpsT and ΔvpsR
strains of V. cholerae, each with wild type (vector, black bars) and
reduced levels of c-di-GMP (pPDE, grey bars). The data were normalized
relative to the wild-type containing vector only, using rpoB as
the reference gene. Shown are the means and standard deviations
from at least three independent samples. For the indicated
comparisons, ***P < 0.001 by unpaired t-testtranscription factors in more subtle ways that are not
apparent using the c-di-GMP depletion strategy.
c-di-GMP inhibits gbpA transcription in a nutrient
dependent manner
GlcNAc and GlcNAc-containing mucin have been
shown to regulate gbpA expression, and to date the only
known transcriptional regulator of gbpA is NagC, a re-
pressor of genes involved in GlcNAc utilization and of
gbpA transcription [36–38]. We sought to determine
how c-di-GMP impacts regulation of the gbpA promoter
in the presence of N-acetylglucosamine (GlcNAc). We
reasoned that GlcNAc, and perhaps other carbohydrates,
may affect c-di-GMP inhibition of gbpA expression, and
that NagC may participate in this process. Specifically,
we postulated that c-di-GMP promotes NagC inhibition
of gbpA expression, such that depletion of c-di-GMP re-
sults in NagC de-repression.
To test the effect of GlcNAc on regulation of gbpA ex-
pression by c-di-GMP, we generated V. cholerae strains
with a translational fusion of lacZ to the gbpA promoter
and 5′UTR, with either pPDE or the vector control.
These strains were grown in a defined medium (M9
minimal medium, MM) supplemented with 0.5 % (w/v)
GlcNAc, glucose, maltose, sucrose, fructose or casamino
acids. The additional carbohydrates were included to ad-
dress whether the potential effect of GlcNAc is specific
to this sugar, and casamino acids were included as a
non-carbohydrate carbon source control. The cultures
were grown to mid-exponential phase (OD600 0.45-0.6),
and expression of gbpA was measured by β-galactosidase
assay, allowing normalization to the optical density of
the culture to adjust for differences in growth due to the
carbon source. Expression of gbpA was variable in the
media tested (Fig. 3, black bars), possibly due to differ-
ences in growth rate with the different carbon sources
(Additional file 2: Figure S2). Compared to V. cholerae
with wild type c-di-GMP levels, reduction of c-di-
GMP led to significantly increased reporter activity in
V. cholerae grown in GlcNAc (1.35-fold), glucose
(1.73-fold), maltose (1.59-fold) and casamino acids
(1.67-fold), but not in bacteria grown in sucrose or
fructose (Fig. 3, grey bars). The results could not be
attributed to growth rate, as depleting c-di-GMP
(pPDE) did not affect overall growth in these media
(Additional file 2: Figure S2). These results indicate
that growth on GlcNAc does not interfere with c-di-
GMP regulation of gbpA expression.
To test whether NagC is required for c-di-GMP inhib-
ition of gbpA expression, pPDE and the control vector
were introduced into V. cholerae with an in-frame dele-
tion of nagC (ΔnagC). Consistent with previous reports
[37, 38], deletion of nagC resulted in 2.2-fold higher
GbpA protein (Fig. 4a) and 1.8-fold higher gbpA
Fig. 3 c-di-GMP inhibition of gbpA expression is influenced by carbon
source availability. V. cholerae strains containing the PgbpA-Vc1-lacZ
reporter fusion, with wild type c-di-GMP (vector, black bars) or reduced
c-di-GMP (pPDE, grey bars), were grown in M9 minimal medium with
0.5 % (w/v) N-acetylglucosamine (GlcNAc), glucose, maltose, sucrose,
fructose or casamino acids at 37 °C with aeration to mid-logarithmic
phase. PDE gene expression was induced as described in the Methods.
Transcription was measured using β-galactosidase assays. Shown are
the means and standard deviations from at least three independent
experiments. For the indicated comparisons, ***P < 0.001 by
unpaired t-test
Fig. 4 Reduction of c-di-GMP induces gbpA expression in a CRP
dependent manner. a GbpA levels in the supernatants of wild type
V. cholerae, ΔnagC and Δcrp strains, each with wild type (vector) and
reduced levels of c-di-GMP (pPDE), were measured by western blot.
PDE gene expression was induced as described in the Methods. The
image shown is a representative of three separate experiments.
Densitometry analyses were done by comparing the intensities of
the GbpA bands to the intensities of a cross-reactive band in the
same lane (indicated by an asterisk), then normalizing the value to
that of wild type V. cholerae with vector. The fold change relative to
the wild type is indicated below each lane. b qRT-PCR was used
to measure the gbpA transcript abundance in wild type, ΔnagC
and Δcrp strains of V. cholerae, each with wild type (vector, black
bars) and reduced levels of c-di-GMP (pPDE, grey bars). The data
were normalized relative to the wild-type containing vector only,
using rpoB as the reference gene. Shown are the means and standard
deviations from at least three independent samples. For the indicated
comparisons, *P < 0.05, ***P < 0.001 by unpaired t-test
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Upon lowering c-di-GMP levels through PDE gene
expression, we observed 20-fold and 2.4-fold increases
in gbpA transcript and GbpA protein, respectively,
comparable to those seen in the wild type background
(Fig. 4a and 4b, respectively). Thus, NagC is not re-
quired for gbpA inhibition by c-di-GMP, corroborating
the lack of an effect of growth with GlcNAc as the
sole carbon source.
Low c-di-GMP induces gbpA transcription in a
cAMP-CRP-dependent manner
In V. cholerae, GlcNAc, sucrose and fructose are solely
imported via a phosphoenolpyruvate-carbohydrate phos-
photransferase system (PTS), and maltose is taken up
via a PTS-independent mechanism [31]. Glucose is a
PTS-substrate that can also be imported via a PTS-
independent pathway, and GlcNAc has been reported to
be a PTS dependent carbohydrate in V. cholerae [31].
However, a V. cholerae nagE mutant, which does not
produce the GlcNAc PTS transporter component, is able
to grow, albeit at a reduced rate, with GlcNAc as the
sole carbon source, suggesting that an alternate GlcNAc
uptake pathway(s) exists [38]. We observed that c-di-
GMP inhibition of gbpA expression did not occur during
growth relying on the strictly PTS-dependent carbohy-
drates sucrose and fructose (Fig. 3), suggesting a de-
pendence of c-di-GMP regulation on carbon source
availability and the mechanism of uptake. Limitation ofPTS-carbohydrates results in increased cAMP biosyn-
thesis and CRP activation, allowing the bacterium to ac-
tivate alternate metabolic pathways [30]. Our results
suggest that c-di-GMP inhibits gbpA transcription when
cAMP-CRP levels are elevated. We thus considered the
possibility that cAMP-CRP regulates gbpA transcription
in a mechanism that is influenced by c-di-GMP levels.
To test the role of CRP in regulating gbpA in response
to c-di-GMP, we generated a V. cholerae Δcrp mutant
and examined it for gbpA production. By western blot,
the Δcrp mutant reproducibly produced ~40 % less
GbpA than the parent strain, supporting a role for CRP
in upregulating GbpA production (Fig. 4a). The gbpA
transcript was also reduced by 53 % in the Δcrp mutant
(Fig. 4b). We next determined the role of CRP in mediat-
ing c-di-GMP regulation of gbpA by assessing expression
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cholerae with the control plasmid, when intracellular c-di-
GMP levels were lowered by PDE production in the Δcrp
strain, there was no change in gbpA transcript or GbpA
protein levels (Fig. 4a and 4b, respectively), indicating that
CRP is required for activation of gbpA expression in re-
sponse to decreased c-di-GMP concentrations.
We next evaluated the role of cAMP in the regulation
of gbpA in V. cholerae. We generated a strain with an
in-frame deletion of cya, which encodes the adenylate
cyclase that synthesizes cAMP, yielding a strain that is
incapable of CRP activation [59]. The cya mutant, like
the CRP mutant, produced less GbpA, with an 80 % de-
crease in protein compared to the wild type (Fig. 5a). A
significant 80 % reduction in gbpA transcript abundance
was also observed in the cya mutant using qRT-PCRFig. 5 Inactivation of the cAMP-CRP signaling pathway prevents
c-di-GMP inhibition of gbpA expression. a GbpA levels in the
supernatants of wild type V. cholerae, ΔcpdA (constitutively active
CRP) and Δcya (constitutively inactive CRP) strains, each with wild
type (vector) and reduced levels of c-di-GMP (pPDE), were measured
by western blot. PDE gene expression was induced as described in the
Methods. The image shown is a representative of three separate
experiments. Densitometry analyses were done by comparing the
intensities of the GbpA bands to the intensities of a cross-reactive band
in the same lane (indicated by an asterisk), then normalizing the value
to that of wild type V. cholerae with vector. The fold change relative to
the wild type is indicated below each lane. b qRT-PCR was used
to measure the gbpA transcript abundance in wild type, ΔcpdA
and Δcya strains of V. cholerae, each with wild type (vector, black
bars) and reduced levels of c-di-GMP (pPDE, grey bars). The data
were normalized relative to the wild-type containing vector only,
using rpoB as the reference gene. Shown are the means and
standard deviations from at least three independent samples. For the
indicated comparisons, *P < 0.05, ***P < 0.001 by unpaired t-test(Fig. 5b). V. cholerae Δcya was then transformed with
pPDE or the control vector, allowing us to determine
the interplay between cAMP and c-di-GMP in control-
ling gbpA expression. When intracellular c-di-GMP was
lowered by PDE production in the Δcya background,
there was no change in gbpA transcript or GbpA pro-
tein levels (Fig. 5a and 5b), mirroring the effect seen
with the crp mutation.
Additionally, we tested the effect of CRP activation on
GbpA production by mutating cpdA, which encodes the
cAMP phosphodiesterase. In this mutant, cAMP cannot
be degraded, and cAMP-CRP complex is constitutively
active [54]. In the cpdA mutant the levels of gbpA tran-
script and GbpA production were comparable the wild
type parent (Fig. 5a and 5b). Reducing c-di-GMP (pPDE)
in the cpdA mutant increased gbpA transcript and GbpA
protein levels by 10.5-fold and 3.2-fold, respectively,
compared to the same strain with unmodified c-di-GMP
(Fig. 5a and 5b). These data further support that cAMP-
CRP activates the expression of gbpA, and indicate that
cAMP and CRP are required for c-di-GMP inhibition of
gbpA expression.
CRP production and activity are not directly affected by
c-di-GMP
We next sought to understand how c-di-GMP influ-
ences CRP-dependent activation of gbpA expression;
c-di-GMP could regulate crp transcription, CRP pro-
tein levels or CRP regulatory activity. To assess the
effect of c-di-GMP on crp expression, crp transcript
levels were measured in V. cholerae with wild type
(vector) or reduced c-di-GMP levels (pPDE). Tran-
script levels of crp were not affected by altering c-di-
GMP (Fig. 6a), suggesting that c-di-GMP directly or
indirectly affects CRP protein levels or activity. The
effect of c-di-GMP on CRP protein levels was deter-
mined by western blot. Lysates from wild type V. cholerae
with vector or pPDE, as well as a crp-null control strain
containing vector, were probed with anti-CRP antibodies.
No differences in CRP abundance were apparent in V.
cholerae with wild type or low c-di-GMP (Fig. 6b).
The identification of a consensus CRP binding site
(GTGAGAGCTTGATTCCACATAT) upstream of gbpA
(and upstream of the Vc1 sequence) using Virtual
Footprint software [60] suggests that CRP interacts dir-
ectly with the gbpA promoter. We postulated that c-di-
GMP may interfere with the DNA-binding activity of
CRP. To test this, we used electrophoretic mobility
shift assays (EMSAs) to evaluate the interactions be-
tween CRP, c-di-GMP and the gbpA promoter. A
293 bp DNA fragment encompassing the gbpA pro-
moter and C-terminally tagged CRP were used, and a
non-specific 133 bp DNA fragment was included as a
negative control in each sample. As observed previously
Fig. 6 c-di-GMP does not regulate CRP gene transcription, protein stability or DNA binding. a Transcript levels for crp in V. cholerae with wild type
(vector) or reduced c-di-GMP (pPDE) were measured by qRT-PCR. PDE gene expression was induced as described in the Methods. The data were
normalized relative to the wild-type containing vector only, using rpoB as the reference gene. Shown are the means and standard deviations from
at three independent samples. b CRP protein (23.6 kDa) levels in lysates of V. cholerae with wild type (vector) or reduced c-di-GMP (pPDE) were
measured by western blot. V. cholerae Δcrp containing vector was included as a negative control. RNA Polymerase was detected on the same blot
as a loading control. The images shown are from a representative of three independent experiments. Densitometry analyses were done
by comparing the intensities of the GbpA bands to the intensities of the RNAP band in the same lane, then normalizing the value to that of wild type
V. cholerae with vector. The fold change relative to the wild type is shown below each lane. c Using electrophoretic mobility shift assays,
purified recombinant CRP was tested for the ability to bind and shift a DNA fragment encompassing the gbpA promoter in the presence
or absence of cAMP and/or c-di-GMP. As a control, a non-specific DNA (indicated by “NS”) fragment was added to all binding reactions
and was confirmed not to be shifted by CRP. *In the final lane, c-di-GMP was added in 10-fold excess of cAMP
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bind the gbpA promoter fragment, but upon addition of
the CRP ligand cAMP, CRP bound and shifted the gbpA
promoter fragment (Fig. 6c). In contrast, the presence of
c-di-GMP did not promote an interaction between CRP
and the promoter fragment. Moreover, the addition of 10-
fold excess c-d-GMP did not interfere with cAMP-CRP
binding to the gbpA promoter. Therefore, in vitro, c-di-
GMP does not influence the binding of cAMP–CRP to
the gbpA promoter.The c-di-GMP and cAMP-CRP signaling pathways act
together on the gbpA promoter, but not other cAMP-CRP
regulatory targets
To determine if c-di-GMP impacts the regulatory func-
tion of CRP, we assessed the regulation of additional
CRP regulatory targets by c-di-GMP. We predicted that
if c-di-GMP was having a global effect on CRP activity,
additional CRP targets would be regulated in a fashion
similar to gbpA. We tested three metabolic genes that
are predicted targets of cAMP-CRP, VC1046, VC2013,
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scriptome analysis identifying CRP and cAMP regulated
genes [33], and we additionally selected them because
they each have a predicted CRP binding site in their pro-
moter (Virtual Footprint) [60]. Our results showed that
relative to the wild type parent strain, transcript levels of
VC1046, VC2013, and VC2544 were reduced by 65 % or
more in the Δcrp background, suggesting that these
genes are positively regulated by CRP (Fig. 7a). Next, we
compared the abundance of these transcripts in wild type
V. cholerae with vector or pPDE to determine whether
manipulation of c-di-GMP affected expression of
these genes. Whereas c-di-GMP depletion resulted in
an 18.5-fold increase in gbpA transcript abundance,
we observed no difference in the abundance of theseFig. 7 cAMP-CRP specifically impacts gbpA expression in response to
c-di-GMP. a Putative CRP-regulated genes were selected for analysis
by qRT-PCR to assess transcript abundance in wild type (grey bars)
and Δcrp (black bars) strains. The data were normalized relative to
the wild-type, using rpoB and gyrA as the reference genes. b The
transcript abundance for the genes analyzed in (a) was determined
for V. cholerae with wild type (vector, grey bars) and reduced levels
of c-di-GMP (pPDE, white bars). The data were normalized relative
to the wild-type containing vector only, using rpoB and gyrA as
the reference genes. a and (b) Shown are the means and standard
deviations from at least three independent samples. For the indicated
comparisons, ***P < 0.001 by unpaired t-testtranscripts in the strain with low c-di-GMP, as compared
to wild type c-di-GMP levels (Fig. 7b). Together, these re-
sults suggest that the effect of low c-di-GMP on CRP ac-
tivity at the gbpA promoter is not a global regulatory
effect and that an additional factor mediates the impact of
c-di-GMP on gbpA transcription initiation.
Discussion
In response to extracellular stimuli, bacteria manipulate
the levels of intracellular second messengers to drive
behavioral changes that promote survival. Herein, we
describe the combined effects of two nucleotide second
messengers, c-di-GMP and cAMP, on transcriptional
regulation of gbpA, a gene encoding a V. cholerae
colonization factor produced in aquatic and host envir-
onmental conditions. Whereas cAMP promotes gbpA
transcription via CRP binding to the gbpA promoter, c-di-
GMP has a negative effect of gbpA promoter activity, and
cAMP-CRP is epistatic to c-di-GMP regulation . As dis-
tinct extracellular cues trigger the c-di-GMP and cAMP
signaling pathways, GbpA production may be modulated
in response to multiple environmental parameters en-
countered by V. cholerae.
Having determined that c-di-GMP negatively affects
gbpA promoter activity, we sought to identify the c-di-
GMP effector that acts on the gbpA promoter. In the
process, we determined that CRP activates gbpA tran-
scription. The CRP protein binds the gbpA promoter in
a cAMP-dependent manner in vitro, and a crp mutant
has somewhat decreased production of GbpA. Moreover,
in the crp mutant, depletion of c-di-GMP did not result
in increased gbpA expression. The same effect was ap-
parent in a cya mutant, which lacks the adenylate cy-
clase responsible for cAMP synthesis (eliminating the
CRP activating signal). The observation that a cAMP
phosphodiesterase (cpdA) mutant, with constitutively ac-
tivated CRP, showed the same increase in GbpA upon c-
di-GMP depletion as the parental strain indicates that
cAMP-CRP promotes gbpA transcription, and only
under CRP-activating conditions is the inhibitory effect
of c-di-GMP on gbpA transcription apparent. Consistent
with this, c-di-GMP inhibition of gbpA expression was
observed during growth on carbon sources that do not
rely on a PTS for uptake (glucose, maltose and casamino
acids)—conditions in which cAMP is produced and CRP
is active [31]. In contrast, growth in media with the
PTS-dependent sugars sucrose and fructose, whose up-
take does not stimulate cAMP production and CRP acti-
vation [31], did not reveal an effect of c-di-GMP. Thus,
c-di-GMP inhibition of gbpA transcription is observable
when cAMP-CRP levels are high. That gbpA transcription
was comparable in the presence of PTS-dependent and in-
dependent nutrient sources was a surprising result given
that we anticipated that growth with PTS carbohydrates
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gbpA expression. However, it is possible that expres-
sion is affected by growth rate, which varies between
growth media.
Given the role of CRP in c-di-GMP regulation of
gbpA expression, we explored the possibility that c-di-
GMP influences CRP at various levels. We excluded ef-
fects of c-di-GMP on CRP gene transcription and protein
abundance. In other bacterial species, c-di-GMP has a dir-
ect role in controlling the activity of CRP-like proteins
[63, 64]. For example, c-di-GMP has been shown to bind
CAP (catabolite activation protein)-like protein CLP from
Xanthomonas campestris, which inhibits its ability to bind
DNA and thus to regulate virulence gene expression [63].
Our data indicate that, while CRP does bind the gbpA pro-
moter in a cAMP-dependent manner, c-di-GMP does not
affect cAMP-CRP binding. Finally, c-di-GMP did not
affect CRP regulatory function, because c-di-GMP did not
broadly affect the expression of other CRP-regulated
genes. Together these findings indicate that c-di-GMP
does not regulate CRP, but regulates another effector that
co-regulates gbpA expression.
Several other potential mediators of c-di-GMP inhib-
ition of gbpA transcription were considered. First, we ex-
amined the role of NagC. Not only was NagC the only
known regulator of gbpA expression [38], the NagC and
CRP regulons were previously linked in E. coli, in which
the NagC and CRP orthologues co-regulate the expression
of genes in the chitobiose operon [65]. While our results
support previous reports indicating that NagC negatively
regulates gbpA, this GlcNAc-responsive regulator had no
impact on c-di-GMP regulation of gbpA expression.
GlcNAc was previously suggested to be a PTS-dependent
sugar in V. cholerae, in which case growth with GlcNAc
as the sole carbon source would not be expected to acti-
vate the cAMP-CRP pathway [31]. However, upregulation
of gbpA was observed upon c-di-GMP depletion during
growth with GlcNAc, mirroring the results obtained dur-
ing growth with PTS-independent nutrients. One possible
explanation for these results is that gbpA is regulated via
multiple mechanisms during growth in GlcNAc (cAMP-
CRP, NagC, c-di-GMP, possibly others), making the net
gbpA transcription level difficult to predict. Alternatively,
GlcNAc, like glucose, may not strictly rely on a PTS for
uptake in V. cholerae. Indeed, although certain PTS com-
ponents are essential for GlcNAc utilization in V. cholerae,
a strain deficient in the EIIBGlcNAc transporter (NagE) re-
tains the ability to grow with GlcNAc as the sole carbon
source [38], suggesting that an additional GlcNAc trans-
porter exists in this bacterium. Thus, an alternative path-
way for GlcNAc transport would alleviate any impact on
the cAMP-CRP pathway.
We directly evaluated three previously defined tran-
scription factors known to bind c-di-GMP in V. cholerae,VpsT, VpsR and FlrA, as potential mediators of gbpA in-
hibition by c-di-GMP. These regulators were compelling
candidates, because gbpA (VCA0811) appeared in tran-
scriptional profiling studies of the respective mutants,
with VpsT and VpsR suggested to act as activators and
FlrA acting as a repressor [20, 58]. However, none of
these transcription factors significantly altered gbpA ex-
pression or c-di-GMP regulation of gbpA. The effector
that senses c-di-GMP and impinges on gbpA expression
remains unidentified.
It is possible that carbon source influences c-di-GMP
levels in V. cholerae. Earlier studies showed cross-talk
between cAMP and c-di-GMP signaling pathways in V.
cholerae. Fong et al. have demonstrated that cAMP-CRP
signaling can impact c-di-GMP production by repressing
the expression of the DGC cdgA, and accordingly, a crp
mutant behaves like a strain with elevated c-di-GMP
levels [33]. To our knowledge, our findings are the first
to link the regulatory effects of both cAMP and c-di-
GMP at a single promoter. Increasing cAMP levels by
inactivating the phosphodiesterase CpdA did not alter
gbpA expression, suggesting that when CRP is maximally
active, c-di-GMP can still inhibit CRP activation of gbpA.
We speculate that direct interplay between cAMP-CRP
and a c-di-GMP regulated factor may impact gbpA tran-
scription such that maximal CRP-dependent activation
of gbpA is apparent under conditions in which cAMP is
abundant and c-di-GMP is low. Alternatively, the two
regulatory events may be independent, and the effect of
c-di-GMP is only observable when cAMP-CRP is
present. Additional studies are needed to determine how
nutrient availability, cAMP-CRP and c-di-GMP interact
to control gbpA expression, and perhaps expression of
other genes.
Previous studies have demonstrated a link between
the available carbon source and surface colonization
by V. cholerae. The ability to respond to PTS carbo-
hydrates is important for binding to chitin, chitin
degradation, and chitin-induced competence [54, 66].
The presence of PTS sugars, mutation of the adenyl-
ate cyclase gene cyaA, and mutation of crp, each of
which reduce or eliminate cAMP-CRP, diminish the
ability of V. cholerae to interact with chitin [66]. As
GbpA also plays a role in colonization of chitin and
intestinal surfaces by V. cholerae [35, 36], it is tempt-
ing to speculate that cAMP-CRP links gbpA expres-
sion with expression of genes encoding chitin
utilization and chitin-induced competence compo-
nents. In addition, in a germ-free mouse model, V.
cholerae requires a functional PTS system to persist
in the intestine, indicating that this bacterium relies
on PTS carbohydrates during infection [31]. cAMP-
CRP also influences expression of numerous other
virulence factors of V. cholerae [32, 59, 67, 68]. Thus
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gram central to surface colonization by V. cholerae.
Genetic evidence suggests that V. cholerae modulates
intracellular c-di-GMP levels during transitions between
its native aquatic environment and the host intestine. Bio-
film formation is positively regulated by c-di-GMP, which
may enhance V. cholerae survival on chitin and other
aquatic surfaces [18, 22, 50]. Indeed, c-di-GMP regulates
the production of at least one other chitin binding protein,
the hemagglutinin FrhA, and has been demonstrated to
promote attachment of V. cholerae to chitin beads [20].
Reduction of c-di-GMP is required to promote bacterial
motility and increase expression of virulence factors
[21, 49, 69–71], and there is evidence suggesting that
V. cholerae may increase c-di-GMP at later stages of
infection [72]. Dysregulation of c-di-GMP signaling
likely affects the ability of V. cholerae to persist in
and transition between these environments.
The data presented here and in previous reports point to
an exceedingly complex regulation of GbpA. In addition to
derepression of gbpA by NagC in response to GlcNAc, we
herein show that high c-di-GMP interferes with cAMP-
CRP activation of gbpA transcription. Thus, the net produc-
tion of GbpA would depend upon the levels of intracellular
cAMP and the c-di-GMP. Another layer of GbpA regula-
tion occurs through post-translational hydrolysis of GbpA
by two quorum sensing regulated proteases, HapA and
PrtV [73]. Cell density-dependent hydrolysis of GbpA may
also be linked to second messenger levels. The quorum
sensing pathway of V. cholerae influences c-di-GMP levels
at least in part through regulation of c-di-GMP metabolism
genes [74, 75]. Quorum sensing is also linked to the
cAMP-CRP signaling pathway in V. cholerae. CRP impacts
the production of the quorum sensing regulator HapR, as
well as synthesis of cholera autoinducer 1 [32, 62, 76].
Thus, the c-di-GMP, cAMP and quorum sensing signaling
networks are intricately intertwined, leading to complex
regulation of GbpA production.
Conclusions
In sum, the transcriptional, post-transcriptional and
post-translational regulation of GbpA may allow V. cho-
lerae to fine-tune GbpA production in response to
changes in intracellular c-di-GMP concentrations. Im-
portantly, numerous extracellular signals that impact
intracellular c-di-GMP and cAMP levels could regulate
GbpA production, influencing the ability of V. cholerae
to colonize aquatic and host surfaces.
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